Ensysce Biosciences, Inc. Skyrocketed
Fri, Feb 27, 2026 at 07:28 PM
Ensysce Biosciences, Inc. (ENSC:NASDAQ) jumped higher at $0.62, a gain of 57.8%. On Fri, Feb 27, 2026, ENSC:NASDAQ hit a New 2-Week High of $0.62. The stock got featured on our News Catalysts scanner on Fri, Feb 27, 2026 at 01:59 PM in the 'BIOTECH' category. From Fri, Feb 13, 2026, the stock recorded 33.33% Up Days and 50.00% Green Days
About Ensysce Biosciences, Inc. (ENSC:NASDAQ)
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs.
Top 10 Gainers:
- KORE Group Holdings, Inc. (KORE:NYSE), 78.64%
- Ensysce Biosciences, Inc. (ENSC:NASDAQ), 57.77%
- Applied Optoelectronics, Inc. (AAOI:NASDAQ), 56.88%
- OneMedNet Corporation (ONMD:NASDAQ), 44.6%
- INNEOVA Holdings Limited (INEO:NASDAQ), 43.9%
- Edesa Biotech, Inc. (EDSA:NASDAQ), 41.94%
- N2OFF, Inc. (NITO:NASDAQ), 38.64%
- Avalon GloboCare Corp. (ALBT:NASDAQ), 36.7%
- Brand Engagement Network, Inc. (BNAI:NASDAQ), 36.13%
- Battalion Oil Corporation (BATL:NYSEMKT), 33.01%